Q3 2023 Holdings
Filed 2023-11-14 | 40 holdings | $650.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $119.1M | 3,130,000 | 18.3% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $51.0M | 4,367,000 | 7.8% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $45.8M | 3,073,750 | 7.0% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $38.6M | 2,369,000 | 5.9% |
| Immunovant Inc(IMVT)Put | COM | 45258J102 | $38.4M | 1,000,000 | 5.9% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $35.3M | 1,968,000 | 5.4% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $32.4M | 1,284,000 | 5.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $28.5M | 655,051 | 4.4% |
| Apellis Pharmaceuticals Inc(APLS)Put | COM | 03753U106 | $25.7M | 675,000 | 3.9% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $25.6M | 971,639 | 3.9% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $20.9M | 759,898 | 3.2% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $18.8M | 1,219,157 | 2.9% |
| Reneo Pharmaceuticals Inc(RPHM) | COM | 75974E103 | $17.4M | 2,279,870 | 2.7% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $16.4M | 1,067,143 | 2.5% |
| Apellis Pharmaceuticals Inc(APLS)Call | COM | 03753U106 | $15.2M | 400,000 | 2.3% |
| An2 Therapeutics Inc(ANTX) | COM | 037326105 | $14.0M | 867,575 | 2.1% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $12.7M | 695,000 | 2.0% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $8.8M | 2,777,778 | 1.3% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $8.6M | 750,000 | 1.3% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $6.8M | 8,187,883 | 1.0% |
| Aerovate Therapeutics Inc | COM | 008064107 | $6.7M | 497,370 | 1.0% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $6.6M | 480,000 | 1.0% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $6.2M | 692,945 | 1.0% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $5.6M | 904,000 | 0.9% |
| Inozyme Pharma Inc | COM | 45790W108 | $5.5M | 1,300,000 | 0.8% |
| Xilio Therapeutics Inc(XLO) | COM | 98422T100 | $4.9M | 2,318,500 | 0.8% |
| Annexon Inc(ANNX) | COM | 03589W102 | $4.8M | 2,050,000 | 0.7% |
| Glycomimetics Inc(GLYCEUR) | COM | 38000Q102 | $4.5M | 3,000,000 | 0.7% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $4.2M | 375,000 | 0.6% |
| Monte Rosa Therapeutics Inc(GLUE) | COM | 61225M102 | $3.9M | 812,895 | 0.6% |
| Jasper Therapeutics Inc | COM | 471871103 | $3.1M | 4,468,114 | 0.5% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $3.1M | 475,600 | 0.5% |
| VIR Biotechnology Inc(VIR) | COM | 92764N102 | $3.0M | 325,050 | 0.5% |
| Travere Therapeutics Inc(TVTX)Call | COM | 89422G107 | $2.7M | 300,000 | 0.4% |
| Lexicon Pharmaceuticals Inc(LXRX) | COM NEW | 528872302 | $2.1M | 1,923,076 | 0.3% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $1.2M | 204,500 | 0.2% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $1.1M | 102,000 | 0.2% |
| Cymabay Therapeutics Inc(CBAYUSD)Put | COM | 23257D103 | $894.6K | 60,000 | 0.1% |
| Bionomics Limited(BNOXN) | ADS | 09063M205 | $453.6K | 168,000 | 0.1% |
| Hepion Pharmaceuticals Inc | COM NEW | 426897302 | $336.8K | 67,500 | 0.1% |